GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Clopidogrel (Primary)
- Indications Acute coronary syndromes; Coronary arteriosclerosis
- Focus Registrational; Therapeutic Use
- Acronyms GRAVITAS
- Sponsors Accumetrics
- 15 Jun 2011 Actual end date changed from Aug 2010 to Oct 2010 as reported by ClinicalTrials..gov. (Parent trial, NCT00645918)
- 15 Mar 2011 Results will be published in the Journal of the American Medical Association, according to an Accumetrics media release.
- 13 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History